Developer docs
API playgroundTry for free, no card

Search company profiles

CHEO Research Institute

Full company profile

uuid000htns

Namestring
CHEO Research Institute
Legal namestring
CHEO Research Institute
Websiteurl
cheoresearch.ca
Company typeenum
Private
Founded yearint
1974
Descriptiontext

CHEO Research Institute is a not-for-profit pediatric research organization affiliated with the Children's Hospital of Eastern Ontario in Ottawa, Canada, founded in 1974 and operating with over 250 researchers and scientists across more than 55 research areas spanning oncology, neuroscience, genetics, mental health, rare diseases, respirology, and digital health. Its core platforms include REDCap (a locally hosted instance of Vanderbilt University's research electronic data capture system) and ROMEO, an internal portal for ethics and grants submissions. Clinical research services are delivered through the Clinical Investigation Unit (CIU), Clinical Research Unit (CRU), Clinical Trial Access Core, SUPPORT Ambassador Program, and a multi-jurisdictional Research Ethics Board holding CTO Qualified REB designation, OCREB partnership, and harmonization agreements with University of Ottawa and Ottawa Hospital Scientific Network.

CHEO RI operates multiple AI/ML research programs including the Data-Driven Discovery Team (machine learning on large health datasets), Mind Matters Team (computer vision for movement disorders), generative AI and digital twin work for clinical trials, and a synthetic data program, with AI modalities spanning structured data, imaging, video, text, and code. Innovation and commercialization activities are run through Core Innovation, which hosts the annual Bears' Den pitch competition (CAD $25,000 investment to the winner), the National Health-Tech Innovation Conference, and the Commercialization Stream providing two-phase clinical validation and regulatory navigation for early-stage health-tech companies.

Revenue is generated through a diversified non-profit model: government research grants (notably a CAD $4M+ Government of Canada investment for the 8-80 Collaborative), industry-sponsored clinical trials (pharmaceutical, biotech, and medical device companies), CHEO Foundation donations, and technology licensing and royalties (such as the SHOEBOX audiometer). Pricing for research ethics review is publicly disclosed (CAD $3,000 for full board initial application, CAD $500 for amendments, renewals, and delegated reviews). The 8-80 Collaborative partnership with Bruyère Health extends the institute's reach across pediatric and geriatric populations, while the Research Connection program auto-enrolls CHEO patients aged 21 and under for study matching via MyChart notifications, phone calls, and in-clinic outreach.

Short descriptiontext

CHEO Research Institute is a not-for-profit pediatric research organization in Ottawa, Canada, affiliated with the Children's Hospital of Eastern Ontario. It conducts clinical and translational research with 250+ scientists across 55+ areas and provides clinical trial services, ethics review, and health-tech commercialization support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pediatric clinical trials, clinical research services, health technology commercialization, research ethics review, medical research support
Industry4 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pediatric Clinical Research Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Government Research Grants
TypeGrants Donations
Description

Funding from federal and provincial government agencies (e.g., Government of Canada's $4M+ investment for 8-80 Collaborative) supporting research programs and innovation initiatives.

cheoresearch.ca
2Industry-Sponsored Clinical Trials
TypeProfessional Services
Description

Revenue from pharmaceutical, biotech, and medical device companies sponsoring clinical trials at CHEO, including both investigator-initiated and industry-sponsored studies.

cheoresearch.ca
3CHEO Foundation Donations
TypeGrants Donations
Description

Charitable donations through CHEO Foundation supporting pediatric research initiatives.

cheoresearch.ca
4Technology Licensing & Commercialization
TypeLicensing Royalties
Description

Revenue from commercialization of health technologies invented at CHEO, such as SHOEBOX portable audiometer, and support services for health-tech startups.

cheoresearch.ca
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details4 tiers
1Full Board Review - Initial Application
ModelOne time/ perpetual licenseBilling cadenceOne-time
Notes

$3,000 for initial application requiring full board review

cheoresearch.ca
2Major Amendment Review
ModelOne time/ perpetual licenseBilling cadenceOne-time
Notes

$500 for major amendments requiring full board review

cheoresearch.ca
3Annual Renewal
ModelSubscriptionBilling cadenceAnnual
Notes

$500 for annual renewal of full board reviewed studies

cheoresearch.ca
4Delegated Review - Industry Sponsored
ModelOne time/ perpetual licenseBilling cadenceOne-time
Notes

$500 initial review fee for studies undergoing delegated review that are industry sponsored or industry initiated

cheoresearch.ca
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 8 records shown
1Bears' Den
Description

Innovation pitch event hosted by Core Innovation where health-tech startups pitch to potential investors

cheoresearch.ca
+7 more records
Core offering1 text field

CHEO Research Institute is a not-for-profit pediatric research organization that conducts clinical and basic science research for children, youth, and families. It operates dedicated pediatric clinical trial infrastructure (Clinical Investigation Unit), provides research support services (Clinical Research Unit, REDCap, ROMEO submission portal), conducts independent ethics review (Research Ethics Board), and supports health-tech commercialization through the Core Innovation program and the 8-80 Collaborative partnership.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 500+ scientific publications per year
+4 more records
Product overview1 text field

CHEO Research Institute is a not-for-profit pediatric research organization offering a comprehensive suite of research support services rather than a commercial product portfolio. Core platforms include REDCap (Vanderbilt University-licensed electronic data capture system locally hosted at CHEO) and ROMEO (internal ethics/grants submission portal). Research services encompass the Clinical Investigation Unit providing dedicated pediatric clinical trial space with specialized nursing and phlebotomy, the SUPPORT Ambassador Program for patient recruitment, and Research Connection for connecting families to studies. The Core Innovation division runs the Bears' Den pitch competition and Commercialization Stream supporting early-stage health-tech companies. The 8-80 Collaborative partnership with Bruyère Health, backed by Government of Canada funding, supports pediatric and geriatric health technology innovators.

Product and service8 records
1Clinical Investigation Unit (CIU)
CategoryClinical Research Service
Description

A dedicated clinical space within the Research Institute designed specifically for pediatric clinical trials. Provides pediatric clinical trial nursing, dedicated research phlebotomy, and private single-bed research space with pediatric-appropriate equipment. Supports both simple and complex trial procedures for industry sponsors and investigator-initiated studies.

2Research Ethics Board (REB) Review Services
CategoryEthics Review Service
Description

Standing committee providing independent, multidisciplinary ethics review of human subjects research conducted by CHEO staff or involving CHEO patients. CTO Qualified REB with harmonization agreements with University of Ottawa, OHSN, and OCREB. Has authority to approve, reject, request modifications, or terminate research.

3Clinical Research Unit (CRU) Services
CategoryResearch Support Service
Description

Team of experienced research professionals offering study design and methodology, statistical analysis, sample size calculation, data management, budget preparation, study logistics, REDCap guidance, and educational opportunities for CHEO investigators.

4Office of Research Services
CategoryResearch Support Service
Description

Multidisciplinary team providing grants support, finance management, contracts, research education, and HR services for research projects at CHEO Research Institute.

5Commercialization Stream
CategoryBusiness Development Service
Description

Supports early-stage health-tech companies with working prototypes seeking to refine and validate products within pediatric/aging clinical settings. Provides two-phase engagement: Scoping/Project Definition followed by Project Execution including expert navigation, clinical validation studies, and regulatory milestone support.

68-80 Collaborative
CategoryInnovation Partnership
Description

Partnership between CHEO Research Institute and Bruyère Health, supported by Government of Canada investment of over $4 million. Connects early-stage health technology innovators with companies delivering solutions for pediatric and geriatric populations over four years.

7Research Connection Program
CategoryPatient Engagement Service
Description

Program connecting families to research opportunities at CHEO. Allows approved researchers to contact CHEO families directly to ask if they would like to learn about specific studies matched to eligibility criteria, using MyChart notifications, phone calls, or in-clinic approaches. Auto-includes children aged 21 and under.

8SUPPORT Ambassador Program
CategoryResearch Support Service
Description

Students Undertaking a Pediatric Program of Research Training - facilitates clinical research activities at CHEO by providing trained volunteers to screen and enroll eligible patients into clinical research studies in the Emergency Department and outpatient/inpatient settings.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-11
Description

The CHEO Research Institute and Bruyère Health partnership established the 8-80 Collaborative with $4M+ Government of Canada investment. The collaboration connects early-stage health innovations from Eastern Ontario health professionals with companies delivering solutions spanning from youth (8 years) to older adults (80+ years).

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-01-01
Description

CHEO has been working with 3D printing company PolyUnity since 2021 to provide in-house 3D printed parts at zero user cost. Over 600 PolyUnity 3D printed parts are already in use across CHEO, including test tube racks, emergency stretcher components, and other healthcare equipment. The technology reduces costs and complexity of traditional healthcare procurement.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

CHEO and OHSN REBs entered into an institutional harmonization agreement in 2019 to streamline ethics review of studies happening at both sites using a single Board of record.

Strategic tierCoreTypeTechnology or Integration
Description

Ottawa-based startup SHOEBOX was founded by CHEO otolaryngologist Dr. Matthew Bromwich. The company developed a tablet-based audiometer enabling hearing testing for more people in more locations. SHOEBOX has been implemented at CHEO and Bruyère Research Institute for pediatric and geriatric patients.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ottawa-based not-for-profit providing women with sewing employment opportunities with focus on recycling and sustainability. Partnered with CHEO on the Ottawa Mask project, providing manufacturing capacity for reusable masks.

6Dessius
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Textile consultancy based in Calgary that collaborated with CHEO on the Ottawa Mask project, providing textile expertise for design and testing of reusable masks.

cheoresearch.ca
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Algonquin College Interactive Media Management program collaborated on production of educational videos explaining roles in clinical research for families.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHEO has an affiliation agreement with University of Ottawa for ethical review of research. University research conducted at or through CHEO requiring human participant recruitment must be reviewed by both CHEO REB and University REB.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHEO has an agreement with OCREB to act as external REB of record for non-phase 1, multi-centre Children's Oncology Group (COG) pediatric clinical trials.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHEO REB was designated a CTO Qualified REB in January 2017. CTO review process is available for full board and minimal risk studies with minimum two CTO participating sites.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ottawa-based non-profit research institute and CHEO's explicit 8-80 Collaborative partner. Directly comparable mission (clinical research, REB, industry-sponsored studies) with adult/geriatric focus that complements CHEO's pediatric identity.

TypeBroad incumbent
Description

Top-ranked U.S. pediatric research hospital, consistently #1 or #2 in NIH pediatric funding. Comparable as a non-profit pediatric research and clinical trial institution but with materially larger research budget and sponsor relationships.

TypeDirect peer
Description

Hospital for Sick Children's research arm in Toronto — Canada's largest pediatric research hospital. Directly comparable as a non-profit pediatric research institute with industry-sponsored trials, REB oversight, and commercialization programs serving similar patient and sponsor segments.

TypeDirect peer
Description

Maritime pediatric and women's health research center in Halifax. Comparable as a regional Canadian non-profit pediatric research institute with similar clinical trial operations, REB functions, and academic partnerships.

TypeDirect peer
Description

Research Institute of the McGill University Health Centre covering the Montreal Children's Hospital. Comparable non-profit pediatric research mandate with similar clinical trial, REB, and academic-affiliation structures across Eastern Canada.

TypeDirect peer
Description

Edmonton-based pediatric hospital and research hub. Comparable as a Western Canadian pediatric research site competing for the same industry-sponsored trial and federal grant pools as CHEO.

TypeDirect peer
Description

Vancouver-based pediatric research institute within BC Children's Hospital. Directly comparable structure: non-profit, university-affiliated, multi-theme research programs, pediatric clinical trial infrastructure, and similar government/foundation funding mix.

TypeBroad incumbent
Description

Largest U.S. pediatric research hospital, affiliated with Harvard. Comparable pediatric research portfolio but at significantly greater scale, with broader international trial sponsorship and a deeper commercialization/tech-transfer operation.

TypeBroad incumbent
Description

Large U.S. pediatric health system with affiliated pediatric research institute. Comparable pediatric clinical trial infrastructure and academic affiliations but operates at broader U.S. scale with multiple hospital campuses.

TypeRegional player
Description

Adjacent Ottawa-based adult research institute with OHSN REB harmonization agreement. Not a direct pediatric competitor but operates in the same geography with comparable REB, clinical trial, and industry-sponsored research services for adult populations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CHEO Research Institute

Pediatric Clinical Research Servicescheoresearch.ca

CHEO Research Institute is a not-for-profit pediatric research organization in Ottawa, Canada, affiliated with the Children's Hospital of Eastern Ontario. It conducts clinical and translational research with 250+ scientists across 55+ areas and provides clinical trial services, ethics review, and health-tech commercialization support.

What CHEO Research Institute does

CHEO Research Institute is a not-for-profit pediatric research organization affiliated with the Children's Hospital of Eastern Ontario in Ottawa, Canada, founded in 1974 and operating with over 250 researchers and scientists across more than 55 research areas spanning oncology, neuroscience, genetics, mental health, rare diseases, respirology, and digital health. Its core platforms include REDCap (a locally hosted instance of Vanderbilt University's research electronic data capture system) and ROMEO, an internal portal for ethics and grants submissions. Clinical research services are delivered through the Clinical Investigation Unit (CIU), Clinical Research Unit (CRU), Clinical Trial Access Core, SUPPORT Ambassador Program, and a multi-jurisdictional Research Ethics Board holding CTO Qualified REB designation, OCREB partnership, and harmonization agreements with University of Ottawa and Ottawa Hospital Scientific Network.

CHEO RI operates multiple AI/ML research programs including the Data-Driven Discovery Team (machine learning on large health datasets), Mind Matters Team (computer vision for movement disorders), generative AI and digital twin work for clinical trials, and a synthetic data program, with AI modalities spanning structured data, imaging, video, text, and code. Innovation and commercialization activities are run through Core Innovation, which hosts the annual Bears' Den pitch competition (CAD $25,000 investment to the winner), the National Health-Tech Innovation Conference, and the Commercialization Stream providing two-phase clinical validation and regulatory navigation for early-stage health-tech companies.

Revenue is generated through a diversified non-profit model: government research grants (notably a CAD $4M+ Government of Canada investment for the 8-80 Collaborative), industry-sponsored clinical trials (pharmaceutical, biotech, and medical device companies), CHEO Foundation donations, and technology licensing and royalties (such as the SHOEBOX audiometer). Pricing for research ethics review is publicly disclosed (CAD $3,000 for full board initial application, CAD $500 for amendments, renewals, and delegated reviews). The 8-80 Collaborative partnership with Bruyère Health extends the institute's reach across pediatric and geriatric populations, while the Research Connection program auto-enrolls CHEO patients aged 21 and under for study matching via MyChart notifications, phone calls, and in-clinic outreach.

CHEO Research Institute firmographics

Firmographics
Name
CHEO Research Institute
Legal name
CHEO Research Institute
Website
https://cheoresearch.ca
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
251–500 employees
Short description
CHEO Research Institute is a not-for-profit pediatric research organization in Ottawa, Canada, affiliated with the Children's Hospital of Eastern Ontario. It conducts clinical and translational research with 250+ scientists across 55+ areas and provides clinical trial services, ethics review, and health-tech commercialization support.
Ownership category
akta.pro rank

CHEO Research Institute industry classification

Industry
Product category
Pediatric Clinical Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support

Keywords

  • Pediatric clinical trials
  • Clinical research services
  • Health technology commercialization
  • Research ethics review
  • Medical research support

Where CHEO Research Institute is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

CHEO Research Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Government Research Grants: Funding from federal and provincial government agencies (e.g., Government of Canada's $4M+ investment for 8-80 Collaborative) supporting research programs and innovation initiatives.
  2. Industry-Sponsored Clinical Trials: Revenue from pharmaceutical, biotech, and medical device companies sponsoring clinical trials at CHEO, including both investigator-initiated and industry-sponsored studies.
  3. CHEO Foundation Donations: Charitable donations through CHEO Foundation supporting pediatric research initiatives.
  4. Technology Licensing & Commercialization: Revenue from commercialization of health technologies invented at CHEO, such as SHOEBOX portable audiometer, and support services for health-tech startups.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseOne-timeFull Board Review - Initial Application
One time/ perpetual licenseOne-timeMajor Amendment Review
SubscriptionAnnualAnnual Renewal
One time/ perpetual licenseOne-timeDelegated Review - Industry Sponsored

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

CHEO Research Institute product offering

Product offering

Core offering

CHEO Research Institute is a not-for-profit pediatric research organization that conducts clinical and basic science research for children, youth, and families. It operates dedicated pediatric clinical trial infrastructure (Clinical Investigation Unit), provides research support services (Clinical Research Unit, REDCap, ROMEO submission portal), conducts independent ethics review (Research Ethics Board), and supports health-tech commercialization through the Core Innovation program and the 8-80 Collaborative partnership.

Product overview

CHEO Research Institute is a not-for-profit pediatric research organization offering a comprehensive suite of research support services rather than a commercial product portfolio. Core platforms include REDCap (Vanderbilt University-licensed electronic data capture system locally hosted at CHEO) and ROMEO (internal ethics/grants submission portal). Research services encompass the Clinical Investigation Unit providing dedicated pediatric clinical trial space with specialized nursing and phlebotomy, the SUPPORT Ambassador Program for patient recruitment, and Research Connection for connecting families to studies. The Core Innovation division runs the Bears' Den pitch competition and Commercialization Stream supporting early-stage health-tech companies. The 8-80 Collaborative partnership with Bruyère Health, backed by Government of Canada funding, supports pediatric and geriatric health technology innovators.

Differentiator

Problem solved

Functional benefit

Brands

  • Bears' Den: Innovation pitch event hosted by Core Innovation where health-tech startups pitch to potential investors
  • Core Innovation
  • 8-80 Collaborative
  • Clinical Investigation Unit (CIU)
  • Clinical Trial Access Core
  • Research Ethics Board (REB)
  • Research Connection
  • SUPPORT Program

Products and services

  • Clinical Investigation Unit (CIU) A dedicated clinical space within the Research Institute designed specifically for pediatric clinical trials. Provides pediatric clinical trial nursing, dedicated research phlebotomy, and private single-bed research space with pediatric-appropriate equipment. Supports both simple and complex trial procedures for industry sponsors and investigator-initiated studies.
  • Research Ethics Board (REB) Review Services Standing committee providing independent, multidisciplinary ethics review of human subjects research conducted by CHEO staff or involving CHEO patients. CTO Qualified REB with harmonization agreements with University of Ottawa, OHSN, and OCREB. Has authority to approve, reject, request modifications, or terminate research.
  • Clinical Research Unit (CRU) Services Team of experienced research professionals offering study design and methodology, statistical analysis, sample size calculation, data management, budget preparation, study logistics, REDCap guidance, and educational opportunities for CHEO investigators.
  • Office of Research Services Multidisciplinary team providing grants support, finance management, contracts, research education, and HR services for research projects at CHEO Research Institute.
  • Commercialization Stream Supports early-stage health-tech companies with working prototypes seeking to refine and validate products within pediatric/aging clinical settings. Provides two-phase engagement: Scoping/Project Definition followed by Project Execution including expert navigation, clinical validation studies, and regulatory milestone support.
  • 8-80 Collaborative Partnership between CHEO Research Institute and Bruyère Health, supported by Government of Canada investment of over $4 million. Connects early-stage health technology innovators with companies delivering solutions for pediatric and geriatric populations over four years.
  • Research Connection Program Program connecting families to research opportunities at CHEO. Allows approved researchers to contact CHEO families directly to ask if they would like to learn about specific studies matched to eligibility criteria, using MyChart notifications, phone calls, or in-clinic approaches. Auto-includes children aged 21 and under.
  • SUPPORT Ambassador Program Students Undertaking a Pediatric Program of Research Training - facilitates clinical research activities at CHEO by providing trained volunteers to screen and enroll eligible patients into clinical research studies in the Emergency Department and outpatient/inpatient settings.

Quantifiable outcome

  • 500+ scientific publications per year
  • +4 more outcomes

Companies that use CHEO Research Institute

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

CHEO Research Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature5 records

CHEO Research Institute partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Bruyère HealthcoreStrategic or Co-development Partner · 11 August 2023The CHEO Research Institute and Bruyère Health partnership established the 8-80 Collaborative with $4M+ Government of Canada investment. The collaboration connects early-stage health innovations from Eastern Ontario health professionals with companies delivering solutions spanning from youth (8 years) to older adults (80+ years).
  • PolyUnitycoreTechnology or Integration · 1 January 2021CHEO has been working with 3D printing company PolyUnity since 2021 to provide in-house 3D printed parts at zero user cost. Over 600 PolyUnity 3D printed parts are already in use across CHEO, including test tube racks, emergency stretcher components, and other healthcare equipment. The technology reduces costs and complexity of traditional healthcare procurement.
  • Ottawa Hospital Scientific Network (OHSN)coreStrategic or Co-development Partner · 1 January 2019CHEO and OHSN REBs entered into an institutional harmonization agreement in 2019 to streamline ethics review of studies happening at both sites using a single Board of record.
  • SHOEBOX LtdcoreTechnology or IntegrationOttawa-based startup SHOEBOX was founded by CHEO otolaryngologist Dr. Matthew Bromwich. The company developed a tablet-based audiometer enabling hearing testing for more people in more locations. SHOEBOX has been implemented at CHEO and Bruyère Research Institute for pediatric and geriatric patients.
  • EcoEquitableminorStrategic or Co-development PartnerOttawa-based not-for-profit providing women with sewing employment opportunities with focus on recycling and sustainability. Partnered with CHEO on the Ottawa Mask project, providing manufacturing capacity for reusable masks.
  • DessiusminorStrategic or Co-development PartnerTextile consultancy based in Calgary that collaborated with CHEO on the Ottawa Mask project, providing textile expertise for design and testing of reusable masks.
  • Algonquin CollegeminorStrategic or Co-development PartnerAlgonquin College Interactive Media Management program collaborated on production of educational videos explaining roles in clinical research for families.
  • University of OttawacoreStrategic or Co-development PartnerCHEO has an affiliation agreement with University of Ottawa for ethical review of research. University research conducted at or through CHEO requiring human participant recruitment must be reviewed by both CHEO REB and University REB.
  • Ontario Cancer Research Ethics Board (OCREB)coreStrategic or Co-development PartnerCHEO has an agreement with OCREB to act as external REB of record for non-phase 1, multi-centre Children's Oncology Group (COG) pediatric clinical trials.
  • Clinical Trials Ontario (CTO)coreStrategic or Co-development PartnerCHEO REB was designated a CTO Qualified REB in January 2017. CTO review process is available for full board and minimal risk studies with minimum two CTO participating sites.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

CHEO Research Institute competitors and assessment

Company assessment

Direct peers

  • Bruyère Research Institute: Ottawa-based non-profit research institute and CHEO's explicit 8-80 Collaborative partner. Directly comparable mission (clinical research, REB, industry-sponsored studies) with adult/geriatric focus that complements CHEO's pediatric identity.
  • SickKids Research Institute: Hospital for Sick Children's research arm in Toronto — Canada's largest pediatric research hospital. Directly comparable as a non-profit pediatric research institute with industry-sponsored trials, REB oversight, and commercialization programs serving similar patient and sponsor segments.
  • IWK Health Centre: Maritime pediatric and women's health research center in Halifax. Comparable as a regional Canadian non-profit pediatric research institute with similar clinical trial operations, REB functions, and academic partnerships.
  • Montreal Children's Hospital Research Institute (RI-MUHC): Research Institute of the McGill University Health Centre covering the Montreal Children's Hospital. Comparable non-profit pediatric research mandate with similar clinical trial, REB, and academic-affiliation structures across Eastern Canada.
  • Stollery Children's Hospital: Edmonton-based pediatric hospital and research hub. Comparable as a Western Canadian pediatric research site competing for the same industry-sponsored trial and federal grant pools as CHEO.
  • BC Children's Hospital Research Institute: Vancouver-based pediatric research institute within BC Children's Hospital. Directly comparable structure: non-profit, university-affiliated, multi-theme research programs, pediatric clinical trial infrastructure, and similar government/foundation funding mix.

Broad incumbents

  • Cincinnati Children's Hospital Medical Center: Top-ranked U.S. pediatric research hospital, consistently #1 or #2 in NIH pediatric funding. Comparable as a non-profit pediatric research and clinical trial institution but with materially larger research budget and sponsor relationships.
  • Boston Children's Hospital: Largest U.S. pediatric research hospital, affiliated with Harvard. Comparable pediatric research portfolio but at significantly greater scale, with broader international trial sponsorship and a deeper commercialization/tech-transfer operation.
  • Children's Healthcare of Atlanta: Large U.S. pediatric health system with affiliated pediatric research institute. Comparable pediatric clinical trial infrastructure and academic affiliations but operates at broader U.S. scale with multiple hospital campuses.

Regional players

  • Ottawa Hospital Research Institute: Adjacent Ottawa-based adult research institute with OHSN REB harmonization agreement. Not a direct pediatric competitor but operates in the same geography with comparable REB, clinical trial, and industry-sponsored research services for adult populations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

CHEO Research Institute social profiles

Digital presence

CHEO Research Institute compliance and trust

Trust signal

Compliance4 records

CHEO Research Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CHEO Research Institute leadership team

Management profile

Number of profiles

Profiles10 records

CHEO Research Institute funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CHEO Research Institute M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHEO Research Institute

What does CHEO Research Institute do?

CHEO Research Institute is a not-for-profit pediatric research organization that conducts clinical and basic science research for children, youth, and families. It operates dedicated pediatric clinical trial infrastructure (Clinical Investigation Unit), provides research support services (Clinical Research Unit, REDCap, ROMEO submission portal), conducts independent ethics review (Research Ethics Board), and supports health-tech commercialization through the Core Innovation program and the 8-80 Collaborative partnership.

Is CHEO Research Institute a public or private company?

CHEO Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CHEO Research Institute founded?

CHEO Research Institute was founded in 1974. It employs 251 to 500 people.

Where is CHEO Research Institute based?

CHEO Research Institute is headquartered in Ottawa, Canada, in the North America region.

How does CHEO Research Institute make money?

Four revenue lines are on record. Government Research Grants are the primary driver. The others are industry-Sponsored Clinical Trials, CHEO Foundation Donations and technology Licensing & Commercialization.

Who are CHEO Research Institute's main competitors?

Direct peers on record are Bruyère Research Institute, SickKids Research Institute, IWK Health Centre, Montreal Children's Hospital Research Institute (RI-MUHC), Stollery Children's Hospital and BC Children's Hospital Research Institute. Broad incumbents are Cincinnati Children's Hospital Medical Center, Boston Children's Hospital and Children's Healthcare of Atlanta. Ottawa Hospital Research Institute is listed as a regional player.

Does CHEO Research Institute have an API?

No public API is recorded for CHEO Research Institute.

What industry is CHEO Research Institute in?

CHEO Research Institute's product category is Pediatric Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAJACAG, Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ottawa Business JournalAI startup spun out of CHEO research lab lands $1.5M in seed fundingWoodway Assurance, a startup spun out of CHEO Research Institute, raised over $1 million in seed funding. Nina Capital invested $500,000 in the company's platform that ensures AI training data complies with privacy laws.Local BreakingHealth care innovation steps into the spotlight at Shark Tank-style CHEO eventThe CHEO Research Institute hosted its 'Bear's Den' pitch competition, a Shark Tank-style event where four Canadian healthcare technology companies presented innovations to judges for a $25,000 prize. Hyivy Health won the grand prize for its pelvic pain technology, while other participants included Neuralign, which pitched a dyslexia reading solution. Event organizers highlighted the broader healthcare crisis affecting children waiting too long for services, stating that technology and innovation are needed to improve outcomes.Yahoo$35 million gift advances precision mental health care at CHEO and SickKids to predict better, diagnose faster and treat smarterThe Waverley House Foundation donated $35 million to CHEO and SickKids to advance precision mental health care for children and youth. The initiative, supported by 14 pilot projects, aims to predict risks earlier and personalize treatment. The partnership seeks to improve outcomes across Canada.GlobeNewswireCHEO Research Institute and Shriners Hospitals for Children Canada Collaborate to Launch First-of-its-kind Joint Pediatric Metabolic and Genetic Bone Disorders FellowshipCHEO Research Institute and Shriners Hospitals for Children Canada launched a joint pediatric metabolic and genetic bone disorders fellowship, with fellows splitting time between Ottawa and Montreal. The first four years are funded by Tunis Shriners of Ottawa, and it is the first of its kind in North America.OhaHealth System News AI Predictive Screening for Autism Spectrum DisorderResearchers from CHEO, BORN Ontario, and the Ottawa Hospital Research Institute developed an AI model to predict autism spectrum disorder using large-scale health data from Ontario. The study demonstrates that machine learning can identify children at increased risk for ASD by age five, potentially enabling earlier diagnosis and resource planning. The team plans to refine the model with new data sources and validate its clinical utility in future phases.